Abstract
Vitamin D (VitD) deficiency is considered a global problem and might be associated with increased susceptibility to COVID‐19 illness. In the light of COVID‐19 pandemic, VitD might be a promising agent for fighting the SARS‐CoV‐2, since VitD is involved in various pathophysiological mechanisms that occur during COVID‐19 infection. High‐dose VitD supplementation, particularly for risk groups, could be recommended to achieve and maintain optimal (range 40‐60 ng/mL) serum 25‐hydroxy vitamin D levels (marker of VitD status) both for COVID‐19 prevention and treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
